ERBB2 and breast carcinoma: However, overexpression of Her-2 in breast cancer cells appears to result from de-repression elements within the 3’ UTR, together with their cognate binding factors, interacting with the 5’ UTR to promote reinitiation at the Her-2 AUG [97].